Growth and the effect of Genotropin in chronically ill children with juvenile rheumatoid arthritis and with Crohn's disease.

Trial Profile

Growth and the effect of Genotropin in chronically ill children with juvenile rheumatoid arthritis and with Crohn's disease.

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 20 May 2015

At a glance

  • Drugs Somatropin (Primary)
  • Indications Crohn's disease; Juvenile rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top